• Absoludy Beta-Amyloid is PIFA Technology(Photooxidation induced Fluorescence Amplification) based quantitative measuring diagnostic test.
• Measuring the level of Beta-Amyloid to diagnose Alzhehimer disease.
The global Alzheimer's Disease (AD) market, worth $2.9 billion in 2016, is predicted to reach $14.8 billion by 2026 across US, Japan, France, Germany, Italy, Spain, and the UK
(the seven major markets), according to business information and analytics company GlobalData. This shows an annual growth rate of 17.5%. [By Pharmaceutical Executive Editors]
|Package Insert sheet
· PIFA technology
Photooxidation induced Fluorescence Amplification;